Home » Research

Cancer Control Program

SELECTED PUBLICATIONS

Audrain, J., Schwartz, M.D., Herrera, J., Goldman, P., and Bush, A. Determinants of physical activity in first-degree relatives of breast cancer patients. J.Behav.Med., 24: 587-603, 2001.

Audrain-McGovern J., Tercyak K.P., Shields A.E., Bush A., Espinel C.F., and Lerman C. Which adolescents are most receptive to tobacco industry marketing? Implications for counter-advertising campaigns. Health Commun., 15: 499-513, 2003.

Benkendorf, J., Peshkin, B.N., and Lerman, C. Impact of genetic information and genetic counseling on public health. In M.J. Khoury, W. Burke, and E. Thomson (eds.), Genetics and Public Health in the 21st Century: Using Genetic Information to Improve Health and Prevent Disease, pp. 361-383. New York: Oxford University Press, 2000.

Berry, D.A., Iversen, E.S., Gudbjartsson, D.F., Hiller, E., Garber, J., Peshkin, B.N., Lerman, C., Watson, P., Lynch, H., Hilsenbeck, S., Rubinstein, W.S., Hughes, K., and Parmigiani, G. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J.Clin.Oncol., 20: 2701-2712, 2002.

Caraceni, A., Bosisio, M., and Ingham, J.M. Confusion and delirium. In D. Schiff and P. Wen (eds.), Cancer Neurology Humana Press, 2001.

Cella, D., Hughes, C., Peterman, A., Chang, C., Peshkin, B.N., Schwartz, M.D., Wenzel, L., Lemke, A., Marcus, A., and Lerman, C. A brief assessment of concerns associated with genetic testing: the multidimensional impact of cancer risk outcomes (MICRO) questionnaire. Health Psychol., 21: 564-572, 2002.

Cheng, J.D., Hitt, J., Koczwara, B., Schulman, K., Burnett, C.B., Gaskin, D., Rowland, J., and Meropol, N.J. Impact of quality of life on patient expectations regarding phase I clinical trials. J.Clin.Oncol., 18: 421-428, 2000.

Cox, L.S., Patten, C.A., Ebbert, J.O., Drews, A.A., Croghan, G.A., Clark, M.M., Wolter, T.D., Croghan, I.T., Offord, K.P., and Hurt, R.D. Tobacco use outcomes among lung cancer patients treated for nicotine dependence: A date-of-treatment matched case-control study. J.Clin.Oncol., 20: 3461-3469, 2002.

Cox, L.S., Patten, C.A., Krahn, L.E., Hurt, R.D., Moyer, T.P., Croghan, I.T., Schroeder, D.R., and Offord, K.P. The effect of transdermal nicotine therapy on depression in non-smokers: Evidence of potential placebo effect. J.Addict.Dis., 2002.

Cox, L.S., Sloan, J.A., Patten, C.A., Bonner, J.A., McGinnis, W.L., Stella, P.J., and Marks, R.S. Smoking behavior change of 215 patients with newly diagnosed stage IIIA/IIIB non-small cell lung cancer. Psychooncology, 11: 1-7, 2002.

Cox, L.S., Tiffany, S.T., and Christen, A.G. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob.Res., 3: 7-16, 2001.

Dale, L.C., Ebbert, J.O., Schroeder, D.R., Croghan, I.T., Rasmussen, D.F., Cox, L.S., and Hurt, R.D. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study. Nicotine Tob.Res., 4: 267-274, 2002.

DeMarco TA, Peshkin BN, Mars BD, Tercyak KP. Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale. J Genet Couns 2004;13:292-304.

DeMarco, T.A., Peshkin, B.N., and Brogan, B.M. Across the spectrum: case studies in genetic counseling for breast and ovarian cancer susceptibility. J.Genet.Couns., 10: 379-395, 2001.

Edge, S.B., Gold, K., Berg, C.D., Meropol, N.J., Tsangaris, T.N., Gray, L., Petersen, B.M., Jr., Hwang, Y.T., and Mandelblatt, J.S. Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Cancer, 94: 2534-2541, 2002.

Gelmann, E.P., Chia, D., Pinsky, P.F., Andriole, G.L., Crawford, E.D., Reding, D., Hayes, R.B., Kramer, B.S., Woodrum, D.L., Gohagan, J.K., and Levin, D.L. Relationship of demographic and clinical factors to free and total prostate-specific antigen. Urology, 58: 561-566, 2001.

Graves, K. D., Schmidt, J.E., Bollmer, J., Fejfar, M., Langer, S., Blonder, L.X., and Andrykowski, M.A. (2005). Emotional expression and emotional recognition in breast cancer survivors: A controlled comparison. Psychology and Health, 20, 579-595.

Graves, K. D., Schmidt, J. E., & Andrykowski, M. A. (2005). Writing about September 11, 2001: Exploration of emotional intelligence and the social environment. Journal of Language and Social Psychology, 24, 289-299.

Green, B.L., Goodman, L., Krupnick, J.L., Corcoran, C.B., Patty, R.M., Stockton, P., and Stern, N.M. Outcomes of single versus multiple trauma exposure in a screening sample. J. Trauma Stress, 13: 271-286, 2000.

Green, B.L., Krupnick, J.L., Rowland, J.H., Epstein, S.A., Stockton, P., Spertus, I., and Stern, N.M. Trauma history as a predictor of psychological symptoms in women with breast cancer. J.Clin.Oncol., 18: 1984-1993, 2000.

Green, B.L., Krupnick, J.L., Stockton, P., Goodman, L., Corcoran, C., and Petty, R. Psychological outcomes associated with traumatic loss in a sample of young women. Amer.Behav.Sci., 44: 817-837, 2001.

Gwaltney, C.J., Shiffman, S., Norman, G.J., Paty, J.A., Kassel, J.D., Gnys, M., Hickcox, M., Waters, A.J., and Balabanis, M. Does smoking abstinence self-efficacy vary across situations? Identifying context-specificity within the relapse situation efficacy questionnaire. J.Consult.Clin.Psychol., 69: 516-527, 2001.

Hadley, J., Polsky, D., Mandelblatt, J.S., Mitchell, J.M., Weeks, J.C., Wang, Q., Hwang, Y.T.; OPTIONS Research Team. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a Medicare population. Health Econ., 12: 171-86, 2003.

Hadley, J., Mandelblatt, J., Mitchell, J., Weeks, J. C., Guadagnoli, E., and Wang, Q. Medicare breast surgery fees and treatment received by older women with localized breast cancer. Health Serv.Res., 38: 553-573, 2003.

Hadley, J., Mitchell, J.M., and Mandelblatt, J. Medicare Fees and small area variations on breast conserving surgery among elderly women. Med. Care Res. Review, 58: 334-360, 2001.

Hagen, M.D., Garber, A., Goldie, S.J., Lafata, J., Mandelblatt, J., Meltzer, D., Neumann, P., Siegel, J., Sox, H.C., Jr., and Tsevat, J. Does cost-effectiveness analysis make a difference? Lessons from pap smears. Med.Decis.Making, 21: 307-323, 2001.

Halbert CH, Schwartz MD, Wenzel L, Narod S, Peshkin BN, Cella D, Lerman C. Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. J Behav Med 2004; 27:373-392.

Halbert CH, Wenzel L, Lerman C, Peshkin BN, Narod S, Marcus A, Corio C, DeMarco T, Bellamy S. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomark Prev 2004;13:875-881.

Halverson, P.K., Mays, G.P., Rimer, B. K., Lerman, C., Audrain, J., and Kaluzny, A.D. Adoption of a health education intervention for family members of breast cancer patients. Am.J.Prev.Med., 18: 189-198, 2000.

Hughes, C., Lerman, C., Schwartz, M., Peshkin, B.N., Wenzel, L., Narod, S., Corio, C., Tercyak, K.P., Hanna, D., Isaacs, C., and Main, D. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am.J.Med.Genet., 107: 143-150, 2002.

Ingham, J.M. and Santoli, F. The epidemiology of physical symptoms associated with progressive medical illnesses. In R.K. Portenoy and et al. (eds.), Shorter Oxford Text of Palliative Care. 2001.

Ingham, J.M. End of life considerations in breast cancer. In J. Harris, M.E. Lippman, M. Morrow, and C.K. Osborne (eds.), Diseases of the Breast, 2nd ed Philadelphia: Lippincott Raven, 2000.

Isaacs C, Fletcher SW, Peshkin BN. Genetic testing for breast cancer. In: Rose BD, ed. UpToDate. Waltham, MA, 2001-2005. (http://www.utdol.com)

Isaacs C, Fletcher SW, Peshkin BN. Options for women with a genetic predisposition to breast cancer. In: Rose BD, ed. UpToDate. Waltham, MA, 2001-2005. (http://www.utdol.com)

Isaacs C, Peshkin BN, Schwartz M. Evaluation and management of women with a strong family history of breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast, Third Edition. Philadelphia, PA: Lippincott Williams & Wilkins, 2004: pages 315-347.

Isaacs C, Peshkin BN, Lerman C. Evaluation and management of women with a strong family history of breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast, Second Edition. Philadelphia: J.B. Lippincott, 2000: pages 237-254.

Isaacs, C. and Peshkin, B.N. Breast cancer, evaluation and screening: risk assessment in women with an inherited predisposition to breast cancer-1. In B. D. Rose (ed.), UpToDate CD-ROM, http://www.uptodate.com ed, Wellesley, MA: 2001.

Isaacs, C., Fletcher, S.W., and Peshkin, B.N. Genetic testing for breast cancer-1. In B.D. Rose (ed.), UpToDate CD-ROM, http://www.utdol.com ed Wellesley, MA: 2002.

Isaacs, C., Fletcher, S.W., and Peshkin, B.N. Options for women with a genetic predisposition to breast cancer. In B.D. Rose (ed.), UpToDate CD-ROM, http://www.utdol.com ed Wellesley, MA: 2002.

Isaacs, C., Peshkin, B.N., Schwartz, M., DeMarco, T.A., Main, D., and Lerman, C. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res.Treat., 71: 103-112, 2002.

Isaacs, C., Peshkin, B.N., and Fletcher, S.W. Genetic testing for breast cancer-1. In B.D. Rose (ed.), UpToDate CD-ROM, http://www.uptodate.com ed Wellesley, MA: 2001.

Kaufman, E.M., Peshkin, B.N., Lawrence, W., Shelby, W., Isaacs, C., Brown, K., Rispoli, J., O'Neill, S., Hurley, K., DeMarco, T.A., Brogan, B.M., Grumet, S., Jandorf, L., Valdimarsdottir, H., and Schwartz, M.D. Development of an interactive decision aid for risk management decision making in female BRCA1/BRCA2 carriers. J.Genet.Couns., 12: 109-129, 2003.

Kerner, J.F., Yedidia, M., Padgett, D., Yabroff, K.R., and Mandelblatt, J.S. Follow-up of abnormal mammograms in Black women. Prev.Med., 37: 92-101, 2003.

Kerner, J.F., Mandelblatt, J.S., Silliman, R.A., Lynch, J.J., Senie, R., Cohen, C., Hwang, Y.T.; OPTIONS Research Team. Outcomes and preferences for treatment in older women nationwide study. Screening mammography and breast cancer treatment patterns in older women. Breast Cancer Res.Treat. 69: 81-91, 2001.

Klassen, A.C., Smith, A.L., Meissner, H.I., Zabora, J., Curbow, B., and Mandelblatt, J. If we gave away mammograms, who would get them? A neighborhood evaluation of a no-cost breast cancer screening program. Prev.Med., 34: 13-21, 2002.

Krupnick, J.L. Interpersonal psychotherapy for PTSD after interpersonal trauma. Directions in Psychiatry, 20: 237-253, 2001.

Krupnick, J.L. The assessment of functional outcomes in cost-effectiveness of psychotherapy studies. In N.E. Miller and K. Magruder (eds.), The Cost-Effectiveness of Psychotherapy: Developing Clinical and Services Research Models in an Era of Health Care Reform. New York: Oxford University Press., 2000.

Kudler, H.S., Blank, A.S., and Krupnick, J.L. Psychodynamic therapy. In E.B. Foa, T.M. Keane, and M.J. Friedman (eds.), Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies, New York: Guilford Press, 2000.

Lapid, M.I., Hall-Flavin, D.K., Cox, L.S., Lichty, E.J., and Krahn, L.E. Smokeless tobacco use among addiction patients: a brief report. J.Addict.Dis., 21: 27-34, 2002.

Lawrence, W.F., Peshkin, B.N., Liang, W., Isaacs, C., Lerman, C., and Mandelblatt, J.S. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer Epidemiol.Biomarkers Prev., 10: 475-481, 2001.

Lerman, C. and Schwartz, M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer, 28: 145-155, 2000.

Lerman, C.E., Hughes, C., Croyle, R.T., Main, D., Durham, C., Snyder, C., Bonney, A., Lynch, J.F., Narod, S.A., and Lynch, H.T. Prophylactic surgery decisions among BRCA1/2 families. Prev.Med., 31: 75-80, 2000.

Lerman, C., Audrain, J., Tercyak, K.P., Hawk, L.W., Bush, A., Crystal-Mansour, S., Rose, C., Niaura, R., and Epstein, L.H. Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patterns among participants in a smoking cessation program. Nicotine Tob.Res., 3: 353-359, 2001.

Lerman, C., Caporaso, N.E., Audrain, J., Main, D., Boyd, N.R., and Shields, P.G. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol.Psychiatry, 5: 189-192, 2000.

Lerman, C., Croyle, R.T., Tercyak, K.P., and Hamann, H. Genetic testing: psychological aspects and implications. J.Consult.Clin.Psychol., 70: 784-797, 2002.

Lerman, C., Schwartz, M.D., Lin, T.H., Narod, S., and Lynch, H.T. The influence of psychological distress on use of genetic testing for cancer risk. J.Consult.Clin.Psychol., 65: 414-420, 2000.

Lerman, C., Schwartz, M., Miller, S., Daly, M., and Rimer, B. Psychological impact of breast cancer risk counseling: interacting effects of coping style and education. Health Psychol., 15: 75-85, 2000.

Liang, W., Burnett, C.B., Rowland, J.H., Meropol, N.J., Eggert, L., Hwang, Y.T., Silliman, R.A., Weeks, J.C., and Mandelblatt, J.S. Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J.Clin.Oncol., 20: 1008-1016, 2002.

Liang, W., Lawrence, W.F., Burnett, C.B., Hwang, Y.T., Freedman, M., Trock, B.J., Mandelblatt, J.S., and Lippman, M.E. Acceptability of diagnostic tests for breast cancer. Breast Cancer Res.Treat., 79: 199-206, 2003.

Mandelblatt, J.S., Edge, S.B., Meropol, N.J., Senie, R., Tsangaris, T., Grey, L., Peterson, B.M. Jr, Hwang, Y.T., Kerner, J., and Weeks, J. Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care. J.Clin.Oncol., 21: 855-63, 2003.

Mandelblatt, J., Lawrence, W., Gaffikin, L., Limpahayom, K., Lumbiganon, P., and Warakamin, S. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J.Natl.Cancer Inst., 94: 1469-1483, 2002.

Mandelblatt, J.S., Armetta, C., Yabroff, K.R., Liang, W., and Lawrence, W.F. A descriptive review of the literature on breast cancer outtcomes. J.Natl.Cancer Inst., 2002.

Mandelblatt, J.S., Kerner, J.F., Hadley, J., Hwang, Y.T., Eggert, L., Johnson, L.E., and Gold, K. Variations in breast carcinoma treatment in older Medicare beneficiaries: is it black or white. J.Clin.Oncol., 95: 1401-1414, 2002.

Mandelblatt, J.S., Edge, S.B., Meropol, N.J., Senie, R., Tsangaris, T., Grey, L., Peterson, B., Hwang, Y.T., and Weeks, J.C. Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma. Cancer, 95: 2445-54, 2002.

Mandelblatt, J.S., Lawrence, W.F., Womack, S.M., Jacobson, D., Yi, B., Hwang, Y.T., Gold, K., Barter, J., and Shah, K. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 287: 2372-1381, 2002.

Mandelblatt, J., Berg, C.D., Meropol, N.J., Edge, S.B., Gold, K., Hwang, Y.T., and Hadley, J. Measuring and predicting surgeons' practice styles for breast cancer treatment in older women. Med.Care, 39: 228-242, 2001.

Mandelblatt, J.S., Bierman, A.S., Gold, K., Zhang, Y., Ng, J., Maserejan, N., Meropol, N. J., Hadley, J., and Silliman, R. Constructs of burden of illness in older breast cancer patients: a comparison of measurement methods. Health Serv.Res., 36: 1085-1107, 2001.

Mandelblatt, J., Hadley, J., Kerner, J., Schulman, K., and et al. Patterns of breast carcinoma treatment in older women: patient preference, clinical, and physician influences. Cancer, 89: 561-573, 2000.

Mandelblatt, J., Yabroff, K.R., Lawrence, W., Yi, B., Orosz, G., Bloom, H.G., Schecther, C.B., Extermann, M., Balducci, L., Satadano, W., Fox, S., Silliman, R., Fahs, M.C., and Muening, P. Screening mammography in the elderly. Research on breast cancer in older women consortium. JAMA, 283: 3202-3204, 2000.

Mandelblatt, J.S. and Yabroff, K.R. Breast and cervical cancer screening in the elderly: recommendations and challenges for the 21st century. J.Am.Med.Womens Assoc., 55: 210-215, 2000.

Martin, M.B., Voeller, H.J., Gelmann, E.P., Lu, J., Stoica, G.E., Hebert, E.J., Reiter, R., Singh, B., Danielsen, M., Pentecost, E., and Stoica, A. Role of cadmium in the regulation of AR gene expression and activity. Endocrinology, 143: 263-275, 2002.

Matloff, E.T., Shappell, H., Brierley, K., Bernhardt, B.A., McKinnon, W., and Peshkin, B.N. What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J.Clin.Oncol., 18: 2492, 2000.

Meyer, B., Pilkonis, P. A., Krupnick, J.L., Egan, M.K., Simmens, S.J., and Sotsky, S.M. Treatment expectancies, patient alliance, and outcome: further analyses from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J.Consult.Clin.Psychol., 70: 1051-1055, 2002.

O'Malley, A.S., and Mandelblatt, J. Delivery of preventative services for lower income persons over age 50: a comparison of community health clinics to private doctors' offices. J.Community Health, 28: 185-197, 2003.

O'Malley, A.S., Forrest, C.B., and Mandelblatt, J. Adherence of low-income women to cancer screening recommendations. J.Gen.Intern.Med., 17: 144-154, 2002.

O'Malley, A.S., Lawrence, W., Liang, W., Yabroff, R., Lynn, J., Kerner, J., and Mandelblatt, J. Feasibility of mobile cancer screening and prevention. J. Health Care Poor Underserved, 13: 298-319, 2002.

O'Malley, A.S., Renteria-Weitzman, R., Huerta, E.E., and Mandelblatt, J. Patient and provider priorities for cancer prevention and control: a qualitative study in Mid-Atlantic Latinos. Ethn.Dis., 12: 383-391, 2002.

O'Malley, A.S., Forrest, C.B., and Shields, P.G. Low income woman's priorities for primary care: a qualitative study. J.Fam.Pract., 49: 141-146, 2000.

Offit K, Garber J, Grady M, Greene MH, Gruber S, Peshkin BN, Rodriguez-Bigas M, Trimbath J, Weitzel J. ASCO Curriculum: Cancer Genetics & Cancer Predisposition Testing, 2nd Edition. Alexandria, VA; ASCO Publishing, 2004.

Padgett, D., Yedidia, M., Kerner, J., and Mandelblatt, J. The emotional consequences of false positive mammography: African-American women's reactions in their own words. Womens Health, 33: 1-14, 2001.

Peshkin BN, Isaacs C. Genetic counseling and psychosocial issues in women with an inherited predisposition to breast cancer. In: Rose BD, ed. UpToDate. Waltham, MA, 2001-2005. (http://www.utdol.com).

Peshkin BN, Isaacs C. Risk assessment in women with an inherited predisposition to breast cancer. In: Rose BD, ed. UpToDate. Waltham, MA, 2001-2005. (http://www.utdol.com)

Peshkin BN. Hereditary breast cancer: BRCA1, BRCA2, and other women at increased risk of breast cancer (role of surveillance, chemoprevention, and prophylactic mastectomy). In: Spear S, et al (eds). Surgery of the Breast: Principles and Art, 2nd Edition. Philadelphia, PA: Lippincott Williams & Wilkins, in press.

Peshkin BN, Lerman CE. Familial breast cancer: genetic testing. In: Cooper DN, ed. Encyclopedia of the Human Genome. London, UK: Nature Publishing Group, 2003. (http://www.ehgonline.net)

Peshkin BN, Isaacs C, Willey S, Schwartz MD. In reply to: Palomares et al., Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practice. J Clin Oncol 2005; in press [reply to letter to the editor].

Peshkin BN, Isaacs C. Evaluation and management of women with BRCA1 and 2 mutations. Oncology, in press.

Peshkin BN, Isaacs C, Finch C, Kent S, Schwartz MD. Tamoxifen as chemoprevention in BRCA1/2 carriers with breast cancer: a pilot survey of physicians. J Clin Oncol 2003;21:4322-4328.

Peshkin, B.N., DeMarco, T.A., and Schwartz, M.D. Oophorectomy in carriers of BRCA mutations. N.Engl.J.Med., 347: 1037-1040, 2002.

Peshkin, B.N. and Isaacs, C. Genetic Counseling and psychosocial issues in women with an inherited predisposition to breast cancer. In B. D. Rose (ed.), UpToDate CD-ROM, http://www.utdol.com ed Wellesley, MA: 2002.

Peshkin, B.N. and Isaacs, C. Risk Assessment in women with an inherited predisposition to breast cancer. In B. D. Rose (ed.), UpToDate CD-ROM, http://www.utdol.com ed Wellesley, MA: 2002.

Peshkin, B.N., Schwartz, M.D., Isaacs, C., Hughes, C., Main, D., and Lerman, C. Utilization of mammography in a clinically-based sample of women following BRCA1/2 testing. Cancer Epidemiol.Biomarkers Prev., 11: 1115-1118, 2002.

Peshkin, B.N., DeMarco, T.A., Brogan, B.M., Lerman, C., and Isaacs, C. The art of oncology: BRCA 1/2 testing: complex themes in result interpretation. J.Clin.Oncol., 19: 2555-2565, 2001.

Pignone, M., Saha, S., Hoerger, T., and Mandelblatt, J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann.Intern.Med., 137: 96-104, 2002.

Polsky, D., Mandelblatt, J.S., Weeks, J.C., Venditti, L., Hwang, Y.T., Glick, H.A., Hadley, J., and Schulman, K.A. Economic evaluation of breast cancer treatment: considering the value of patient choice. J.Clin.Oncol. 21: 1139-46, 2003.

Saha, S., Hoerger, T.J., Pignone, M., Teutsch, S.M., Helfand, M., and Mandelblatt, J.S. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services. Am.J.Prev.Med., 20: 36-43, 2001.

Sawaya, G.F., Grady, D., Kerlikowske, K., Hickcox, M., and Mandelblatt, J. Advancing age and cervical cancer screening and prognosis. J.Am.Geriatr.Soc., 49: 1499-1504, 2001.

Sawaya, G.F., Grady, D., Kerlikowske, K., LaValleur, J., Barnabei, V.M., Bass, K., Snyder, T.E., Pickar, J.H., Agarwal, S., and Mandelblatt, J. The positive predictive value of cervical smears in previously screened post-menopausal women: the heart and estrogen/progesterone replacement study (HERS). Ann.Intern.Med., 133: 942-950, 2000.

Schutta, K.M. and Burnett, C.B. Factors that influence a patient's decision to participate in a phase I cancer clinical trial. Oncol.Nurs.Forum, 27: 1435-1438, 2000.

Schwartz M. Familial and genetic risk. In: Morrow M, Jordan VC, eds. Managing Breast Cancer Risk. Ontario, Canada: B.C. Decker, 2003: pages 26-42.

Schwartz MD, Tercyak KP, Peshkin BN, Valdimarsdottir H. Practice point: Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility? Nature Clin Prac Oncol 2005;2:24-25 [invited commentary].

Schwartz MD, Peshkin BN, Isaacs C. In reply to: Eisinger et al., The choice of bilateral prophylactic mastectomy. J Clin Oncol 2005;23:1331-1332 [reply to letter to the editor].

Schwartz MD, Peshkin BN, Tercyak KP, Taylor KL, Valdimarsdottir H. Decision making and decision support for hereditary breast-ovarian cancer susceptibility. Health Psychology, in press.

Schwartz MD, Lerman C, Brogan B, Peshkin BN, Isaacs C, DeMarco T, Halbert Hughes C, Pennanen M, Finch C. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomark Prev 2005;14:1003-1007.

Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, Lawrence W, Main D, Magnant C, Pennanen M, Tsangaris T, Willey S, Isaacs C. Impact of BRCA1/BRCA2 counseling and testing in newly diagnosed breast cancer patients. J Clin Oncol 2004;22:1823-1829.

Schwartz MD, Kaufman E, Peshkin BN, Isaacs C, Hughes C, DeMarco T, Finch C, Lerman C. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. J Clin Oncol 2003;21:4034-4041.

Schwartz, M.D., Taylor, K.L., and Willard, K. Prospective association of distress and mammography among women with a family history of breast cancer. J.Behav.Med., 26: 105-117, 2003.

Schwartz, M.D. and Peshkin, B. Multidisciplinary genetic assessment has similar psychological impact to usual care for women at high risk of familial breast cancer. Evidence-Based Oncology, 2002.

Schwartz, M.D., Peshkin, B.N., Hughes, C., Main, D., Isaacs, C., and Lerman, C. The impact of BRCA1/BRCA2 mutation testing on psychological distress in a clinic-based sample. J.Clin.Oncol., 20: 514-520, 2002.

Schwartz, M.D., Rothenberg, K.H., Joseph, L., Benkendorf, J., and Lerman, C. Consent to the use of stored DNA for genetics research: a survey of attitudes in the Jewish population. Am.J.Med.Genet., 98: 336-342, 2001.

Schwartz, M.D., Benkendorf, J., Lerman, C., Isaacs, C., Ryan, A., and Johnson, L. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/2 testing among Ashkenazi Jewish women. Cancer, 92: 932-940, 2001.

Schwartz, M.D., Lerman, C., and Rimer, B.K. Psychosocial interventions for women at increased risk for breast cancer. In A. Baum and B. Anderson (eds.), Psychosocial Interventions in Behavioral Medicine, Washington, DC: APA, 2001.

Schwartz, M.D., Hughes, C., Roth, J., Main, D., Peshkin, B.N., Isaacs, C., Kavanagh, C., and Lerman, C. Spiritual faith and genetic testing decisions among high risk breast cancer probands. Can.Epid.Biomarkers.Prev., 9: 381-385, 2000.

Schwartz, M.D., Jacobsen, P.B., Bovbjerg, D.H., Redd, W.H. The role of nausea in the development of conditioned taste aversions among cancer chemotherapy patients. Physiol.Behav., 59: 659-663, 2000.

Shapira, M.M., Lawrence, W.F., Katz, D., McAuliffe, T.L., and Nattinger, A.B. Effect of treatment on quality of life among men with clinically localized prostate cancer. Med.Care, 39: 243-253, 2001.

Shelby, R.A., Stoddart, R.M., and Taylor, K.L. Factors contributing to levels of burnout among sex offender treatment providers. J.Interpersonal Violence, 16: 1205-1217, 2001.

Shelby, R.A., Taylor, K.L., Kerner, J.F., Coleman, E., and Blum, D. The role of community-based and philanthropic organizations in meeting cancer patient and caregiver needs. CA Cancer J.Clin., 52: 229-246, 2002.

Shields, A.E., Finkelstein, A., Comstock, C., and Weiss, K.B. Process of care for Medicaid-enrolled children with asthma served by community health centers and other providers. Med.Care, 40: 303-314, 2002.

Stearns, V., Isaacs, C.J., Rowland, J., Crawford, J., Ellis, M.J., Kramer, R.A., Lawrence, W., Hanfelt, J.J., and Hayes, D.F. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann.Oncol., 11: 17-22, 2000.

Streisand, R. and Tercyak, K.P. Evaluating the pediatric transplant patients: general considerations. In J.R. Rodrigue (ed.), Biopsychosocial Perspectives on Transplantation., pp. 71-92. New York: Kluwer Academic/Plenum Publishers, 2002.

Streisand, R. and Tercyak, K.P. Parenting children with chronic medical illness: considerations and challenges. In N. Long and M. Hoghughi (eds.), Sage Handbook of Parenting, London,U.K.: Sage Publications., in press 2003

Streisand, R., Branecki, S., Tercyak, K.P., and Kazak, A.E. Childhood illness-related parenting stress: the pediatric inventory for parents. J.Pediatr.Psychol., 26: 155-162, 2001.

Swan, J.S., Fryback, D., Lawrence, W.F., Sainfort, F., Hagenauer, M.E., and Heisey, D.M. A time-tradeoff method for cost-effectiveness models applied to radiology. Med.Decis.Making, 79-88, 2000.

Taylor, K.L., Africano, N.L., Cox, L.S., Tercyak, K.P., Waters, A.J., Shields, P.G., Gelmann, E.P., and Neff, S.E. Tobacco use among lung cancer screening participants (abstract). Can.Epid.Biomarkers.Prev., 12: 184, 2003.

Taylor, K.L., Lamdan, R.M., Siegel, J., Shelby, R.A., Hrywna, M., and Moran-Klimi, K. Sexual attractiveness concerns, treatment regimen, and psychological adjustment among African American breast cancer patients. Psychooncology, 11: 505-517, 2002.

Taylor, K.L., Shelby, R.A., Kerner, J.F., Redd, W.H., and Lynch, J. The impact of undergoing prostate cancer screening on prostate cancer-related knowledge and distress. Cancer, 95: 1037-1044, 2002.

Taylor, K.L., Shelby, R.A., Schwartz, M.D., Ackerman, J., LaSalle, V.H., Gelmann, E.P., and McGuire, C. The impact of item order on ratings of cancer risk perception. Can.Epid.Biomarkers.Prev., 11: 654-659, 2002.

Taylor, K.L., Davis, J.L., Turner, R.O., Kerner, J.F., Schwartz, M.D., Johnson, L., and Leak, C. Improving knowledge of the prostate cancer screening dilemma among African American men: a community/academic partnership in Washington, DC. Public Health Rep., 116: 590-598, 2001.

Tercyak KP, DeMarco TA, Mars BD, Peshkin BN. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects. Am J Med Genet 2004;131A:36-41.

Tercyak KP, Beville KW, Peshkin BN. Psychological aspects of prenatal genetic counseling and testing: issues for women's health care. Mental Fitness 2003;2:74-82.

Tercyak KP, Peshkin BN, Walker LR, Stein MA. Cigarette smoking among youth with attention-deficit/hyperactivity disorder: clinical phenomenology, comorbidity, and genetics. J Clin Psychol Med Settings 2002;9:35-50.

Tercyak, K.P., Peshkin, B.N., DeMarco, T.A., Brogan, B.M., and Lerman, C. Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient.Educ.Couns., 47 : 145-153, 2002.

Tercyak, K.P., Cox, L.S., and Shields, P.G. Genetic influences on smoking behavior: The role of biomarkers in tobacco control. In S.M. Miller (ed.), Individuals, Families, and the New Genetics. New York, NY: W.W. Norton, 2002.

Tercyak, K.P., Goldman, P., Smith, A., Shields, A., and Audrain, J. Interacting effects of depression and tobacco advertising receptivity on adolescent smoking. J.Pediatr.Psychol., 27: 145-154, 2002.

Tercyak, K.P., Lerman, C., and Audrain, J. Association of attention-deficiency/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J.Am.Acad.Child Adolesc.Psychiatry, 41: 799-805, 2002.

Tercyak, K.P., Hughes, C., Main, D., Snyder, C., Lynch, J.F., Lynch, H.T., and Lerman, C. Parental communication of BRCA1/2 genetic test results to children. Patient.Educ.Couns., 42: 213-224, 2001.

Tercyak, K.P., Johnson, S.B., Roberts, S.F., and Cruz, A.C. Psychological response to prenatal genetic counseling and amniocentesis. Patient.Educ.Couns., 43: 73-84, 2001.

Tercyak, K.P., Lerman, C., Peshkin, B.N., Hughes, C., Main, D., Isaacs, C., and Schwartz, M. Effects of coping styles and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol., 20: 217-222, 2001.

Tercyak, K.P., Peshkin, B.N., Streisand, R., and Lerman, C. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants. Psychooncology, 10: 336-346, 2001.

Tercyak, K.P., Streisand, R., Peshkin, B.N., and Lerman, C. Psychosocial impact of predictive testing for illness on children and families: challenges for a new millennium. J.Clin.Psychol.Med.Settings, 7: 55-68, 2000.

Waters, A.J. and Feyerabend, C. Determinants and effects of attentional bias in smokers. Psycho.Addict.Behav., 14: 111-120, 2000.

Waters, A.J. and Sutton, S. Direct and indirect effects of nicotine/smoking on cognition in humans. Addict.Behav., 25: 29-43, 2000.

Yabroff, K.R., Mangan, P., and Mandelblatt, J. Effectiveness of interventions to increase Papanicolaou smear use. J.Am. Board Fam.Pract., 16:188-203, 2003.

Yabroff, K.R., O'Malley, A.S., Mangan, P.A., and Mandelblatt, J.S. Inreach and outreach interventions to improve mammography use. J.Am.Med.Womens Assoc., 56: 166-173, 2001.

Yabroff, K.R., Brown, R., and Halpern, M. Breast cancer epidemiology, prevention and costs of care: implications for disease management. Dis.Manage Health Outcomes, 8: 197-210, 2000.

Yabroff, K.R., Mandelblatt, J., and Kerner, J. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening. Prev.Med., 31: 429-439, 2000.

Zuroff, D.C., Blatt, S.J., Sotsky, S.M., Krupnick, J.L., Martin, D.J., Sanislow, C.A., and Simmens, S. Relation of therapeutic alliance and perfectionism to outcome in brief outpatient treatment of depression. J.Consult.Clin.Psychol., 68: 114-124, 2000.